Glen M. Davis | |
---|---|
Born | |
Awards | OAM, FACSM |
Academic background | |
Education | University of Toronto (PhD), University of Western Ontario (MA), University of Ottawa (BPE) |
Academic work | |
Discipline | Exercise therapy |
Institutions | University of Sydney |
Doctoral students | Sirous Ahmadi |
Glen Macartney Davis OAM (born January 30,1952) is an Australian-Canadian scientist who is Professor of Clinical Exercise Sciences at the University of Sydney. [1] [2]
Davis received his undergraduate and post-graduate education in Canada,with his Ph.D. degree being conferred at the University of Toronto in 1986. Davis is a member of several international scientific societies including a Fellow of the American College of Sports Medicine and Vice President of the International Functional Electrical Stimulation Society. Since 1985,he has conducted a variety of invited workshops,lectures and symposia with international scope in his research area of Exercise Therapy in Special Populations. In addition,he has published 15 book chapters,over 68 peer-reviewed articles and more than 76 research abstracts or abbreviated communications in proceedings of scientific meetings. Traditionally,Davis has maintained a strong research and clinical interest in:
Since 2000,Davis has been Principal/Chief Investigator on research grants exceeding $A4.39M including current Australian NHMRC and NSW Program Grant funding. [3] [4]
Physical therapy (PT),also known as physiotherapy,is one of the allied health professions. It is provided by physical therapists who promote,maintain,or restore health through physical examination,diagnosis,prognosis,patient education,physical intervention,rehabilitation,disease prevention,and health promotion. Physical therapists are known as physiotherapists in many countries.
Magnetic therapy is a pseudoscientific alternative medicine practice involving the weak static magnetic field produced by a permanent magnet. It is similar to the alternative medicine practice of electromagnetic therapy,which uses a magnetic field generated by an electrically powered device.
Fibromyalgia (FM) is a medical condition defined by the presence of chronic widespread pain,fatigue,waking unrefreshed,cognitive symptoms,lower abdominal pain or cramps,and depression. Other symptoms include insomnia and a general hypersensitivity. Patients with fibromyalgia are more likely to suffer from depression,anxiety and posttraumatic stress disorder.
Functional electrical stimulation (FES) is a technique that uses low-energy electrical pulses to artificially generate body movements in individuals who have been paralyzed due to injury to the central nervous system. More specifically,FES can be used to generate muscle contraction in otherwise paralyzed limbs to produce functions such as grasping,walking,bladder voiding and standing. This technology was originally used to develop neuroprostheses that were implemented to permanently substitute impaired functions in individuals with spinal cord injury (SCI),head injury,stroke and other neurological disorders. In other words,a person would use the device each time he or she wanted to generate a desired function. FES is sometimes also referred to as neuromuscular electrical stimulation (NMES).
Electrotherapy is the use of electrical energy as a medical treatment. In medicine,the term electrotherapy can apply to a variety of treatments,including the use of electrical devices such as deep brain stimulators for neurological disease. The term has also been applied specifically to the use of electric current to speed wound healing. Additionally,the term "electrotherapy" or "electromagnetic therapy" has also been applied to a range of alternative medical devices and treatments.
The Lions Eye Institute (LEI) is an Australian medical research institute affiliated with the University of Western Australia. It was established in 1983 with support of the Lions Clubs of Western Australia and headquartered in the Perth suburb of Nedlands,Western Australia. The LEI is a not-for-profit centre of excellence that combines an ophthalmic clinic with scientific discovery developing techniques for the prevention of blindness and the reduction of pain from blinding eye conditions.
Graeme Milbourne Clark AC is an Australian Professor of Otolaryngology at the University of Melbourne. His work in ENT surgery,electronics and speech science contributed towards the development of the multiple-channel cochlear implant. and his invention was later produced and sold by Cochlear Limited.
The European Organisation for Research and Treatment of Cancer (EORTC) is a unique pan-European non-profit clinical cancer research organisation established in 1962 operating as an international association under Belgium law. It develops,conducts,coordinates and stimulates high-quality translational and clinical trial research to improve the survival and quality of life of cancer patients. This is achieved through the development of new drugs and other innovative approaches,and the testing of more effective therapeutic strategies,using currently approved drugs,surgery and/or radiotherapy in clinical trials conducted under the auspices of a vast network of clinical cancer researchers supported by 220 staff members based in Brussels. The EORTC has the expertise to conduct large and complex trials especially specific populations such as the older patient and rare tumours.
Stefan Ślopek (1 December 1914 in Skawa near Kraków –22 August 1995,Wrocław was a Polish scientist specializing in clinical microbiology and immunology.
Robert Galbraith Heath was an American psychiatrist. He followed the theory of biological psychiatry that organic defects were the sole source of mental illness,and that consequently mental problems were treatable by physical means. He published 425 papers and three books. One of his first papers is dated 1946.
The International Neuromodulation Society (INS) is a non-profit group of clinicians,scientists and engineers dedicated to the scientific development and awareness of neuromodulation –the alteration of nerve activity through the delivery of electromagnetic stimulation or chemical agents to targeted sites of the body. Neuromodulation is a burgeoning field –analysts forecast a double-digit annual growth rate through 2026. Founded in 1989 and based in San Francisco,CA,the INS educates and promotes the field through meetings,its bimonthly,peer-reviewed journal Neuromodulation:Technology at the Neural Interface and chapter websites.
Pulsed electromagnetic field therapy,also known as low field magnetic stimulation (LFMS) uses electromagnetic fields in an attempt to heal non-union fractures and depression. By 2007 the FDA had cleared several such stimulation devices.
Dr. Omar Fakhri - الدكتورعمرفخري–B.Sc.,M.Sc.,Ph.D. FRCPath is a medical scientist who is best known for his research in several areas:the role of vitamin K in treating hemorrhagic diathesis in children,the cooperation between antibodies and lymphocytes and their role in immune response,the use of peritoneal macrophages in the treatment of resistant infections in leukemia patients,the effect of electroconvulsive therapy on diabetes and the use of low voltage electrotherapy in the treatment of resistant skin burns,psoriasis,exophthalmos,aplastic anaemia and other diseases.
Jozef Cywinski is a Polish-American scientist,a specialist in the field of biomedical engineering and specifically in electrical stimulation of living organisms. His work has been the subject of 12 patents,two books and over 100 scientific publications. He developed several first-on-the-market electro-medical devices like cardiac stimulators pacemakers,train-of-four nerve stimulators,PACS,EMS,TENS and Veinoplus calf pump stimulators.
Neuromodulation is "the alteration of nerve activity through targeted delivery of a stimulus,such as electrical stimulation or chemical agents,to specific neurological sites in the body". It is carried out to normalize –or modulate –nervous tissue function. Neuromodulation is an evolving therapy that can involve a range of electromagnetic stimuli such as a magnetic field (rTMS),an electric current,or a drug instilled directly in the subdural space. Emerging applications involve targeted introduction of genes or gene regulators and light (optogenetics),and by 2014,these had been at minimum demonstrated in mammalian models,or first-in-human data had been acquired. The most clinical experience has been with electrical stimulation.
Richard Crevenna is an Austrian medical specialist,Head of the Department of Physical Medicine,Rehabilitation and Occupational Medicine,Professor for physical medicine and a medical specialist for general rehabilitation with the special subject geriatrics,Pain Medicine,Geriatrics,and Occupational Medicne at the Medical University of Vienna (MUW). He is known for his basic work on cancer rehabilitation,interdisciplinary pain medicine and biofeedback.
Ban Tsui is a Canadian anesthesiologist known for medical innovation in the field of anesthesia. Examples include describing the Tsui Test and developing the StimuLong Sono-Tsui for ease of pediatric epidural placement. Recently along with his son,Jenkin Tsui,Dr. Tsui developed a catheter-over-needle kit allowing a continuous catheter placement to be performed with the ease of a single shot during peripheral nerve blocks.
The Bionics Institute of Australia is a biomedical research institute focusing on medical bionics that creates,designs,evaluates and improves bionic devices that interface with the human body to restore impaired sensory or other nervous system and bodily functions. The Bionics Institute is located in Melbourne,Australia.
Milos R. Popovic is a scientist specializing in Functional Electrical Stimulation (FES) and neurorehabilitation. As of 2018,he is Director of the KITE Research Institute at UHN Toronto Rehabilitation Institute (TRI),and a Professor with the Institute of Biomaterials and Biomedical Engineering at the University of Toronto.
Jason C. Kovacic is an Australian-born cardiologist and physician-scientist;the Robert Graham Chair and Professor of Medicine,University of New South Wales;Executive Director of the Victor Chang Cardiac Research Institute in Sydney,Australia;and Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai,New York.